NCT05839769

Evaluation of Carpal Tunnel Syndrome in Pregnancy

Completed Last updated 4 October 2023

What this trial tests

trial testing Evaluation of median nerve with ultrasound in Carpal Tunnel in 60 participants. Completed in 10 September 2023.

Timeline

10 April 2023

Primary endpoint
10 July 2023

10 September 2023

Quick facts

Lead sponsor	Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Status	Completed
Study type	OBSERVATIONAL
Enrollment	60
Start date	10 April 2023
Primary completion	10 July 2023
Estimated completion	10 September 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

• Evaluation of median nerve with ultrasound

Conditions studied

• Carpal Tunnel — all drugs for Carpal Tunnel →
• Carpal Tunnel Syndrome — all drugs for Carpal Tunnel Syndrome →

Sponsor

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Who can join

Adults 18 to 40, female only, with Carpal Tunnel or Carpal Tunnel Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Carpal tunnel syndrome (CTS) is a condition that happens when the median nerve in the wrist gets compressed, causing pain, numbness, and tingling in the hand and fingers. It's a common condition that affects between 3% and 6% of people in the general population.

During pregnancy, CTS can be a bigger problem because hormonal changes can cause swelling and put more pressure on the median nerve. Studies show that CTS can affect up to 45% of pregnant women, making it important to identify and manage.

CTS can be diagnosed through a physical exam by a doctor, who will check for symptoms like pain, tingling, or weakness in the hand and fingers. Ultrasound can also be used to diagnose CTS by measuring the size of the median nerve in the wrist. This is a non-invasive imaging technique that is generally considered reliable for diagnosing CTS.

In previous studies, ultrasound has been used to measure the size of the median nerve in pregnant women with carpal tunnel syndrome (CTS). However, a new ratio of median nerve cross-sectional area to flexor carpi radialis cross-sectional area (MN-CSA/FCR-CSA) has not been studied in pregnant women. This ratio may be a more sensitive diagnostic tool for CTS because it is not affected by swelling, which is a common symptom during pregnancy that can affect the size of the median nerve.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.